Delays in the development of new corona therapeutic agents and reduced revenues at medical institutions Discussions at academic societies

Delay in development of new corona therapeutic drug and decrease in revenue at medical institutions Discussion at academic society October 2, 20:49

A panel discussion was held in which the top management of academic societies and research institutes discussed the impact of the spread of the new coronavirus on medical care, and administrative support was given to issues that became apparent, such as delays in the development of therapeutic drugs and a decrease in revenue at medical institutions. There was an opinion that it was necessary.

The panel discussion was held at the Japanese Cancer Association held in Hiroshima City, and the top executives of academic organizations and research institutes exchanged opinions.

Among them, Yasuhiro Fujiwara, chairman of the Pharmaceuticals and Medical Devices Agency, an independent administrative agency that examines drugs, said, "Overseas, a large research organization is effective in February for the development of therapeutic drugs for the new coronavirus. with a prospect to carry out clinical trials to verify, had announced the results in the summer. in Japan, we pointed out that "is behind only observational studies can not be used to the approval of the data even if the administration of the medicine pharmaceuticals ..

He added, "Securing medicines originating in Japan is related to security. It is necessary to establish a system to support clinical trials in preparation for a crisis."

In addition, Tetsuo Noda, managing director of the Japanese Foundation for Cancer Research, said, "Many medical institutions and research institutes are experiencing a decline in revenue," after clarifying that the number of consultations at hospitals has decreased and sales have declined by billions of yen. Support by the government is indispensable. "

In response to these opinions, Mr. Masafumi Sakoi, director of the Ministry of Health, Labor and Welfare, replied, "We will consider the maximum support as a country, but it is not enough to solve it, and we need to have people think about things that will change."